[1] |
Wang Li, Ren Zengguo, Lou Guiyu, Zhang Yuwei, Yang Ke, Lei Xingxing, Zhang Bing, Liao Shixiu, Hao Bingtao.
Genetic diagnosis in two families with dystrophic epidermolysis bullosa
[J]. Chinese Journal of Dermatology, 2023, 56(8): 770-773.
|
[2] |
Li Yue, Wu Jinyan, Yuan Ruoyue, Yang Quyang, Zhao Xiansheng, Zhu Ningwen.
Cell therapy for hereditary epidermolysis bullosa
[J]. Chinese Journal of Dermatology, 2023, 56(7): 698-702.
|
[3] |
Su Chang, Sui Xiuli, Liu Ruiling, Cao Yiqun, Jiang Hong, Yan Cairong, Wang Huiping, Qi Yuqing.
Omalizumab for the treatment of 74 patients with chronic spontaneous urticaria accompanied by other allergic diseases: a clinical analysis
[J]. Chinese Journal of Dermatology, 2023, 56(6): 512-517.
|
[4] |
Committee on Psoriasis, Chinese Society of Dermatology.
Expert consensus on treat-to-target approach for the treatment of psoriasis with biological agents
[J]. Chinese Journal of Dermatology, 2023, 56(3): 191-203.
|
[5] |
Li Xiuzhen, Xu Xiulian.
Effects of interleukin-23 inhibitors on psoriasis comorbidities
[J]. Chinese Journal of Dermatology, 2023, 0(2): 20210809-e20210809.
|
[6] |
Yang Ying, Guo Qing, Hou Suchun, Min Xue, Tian Jiabin, Qiao Zhuhui, Lin Jialin, Wang Xiaofei, Wu Lantuya, Zhang Zhenying, Li Zhengfeng, Wang Bin, Liu Xiaoming.
COVID-19 vaccination status and its impact on psoriatic lesions in patients with psoriasis treated with biologics: a single-center cross-sectional study
[J]. Chinese Journal of Dermatology, 2023, 56(1): 59-63.
|
[7] |
Bao Yingqiu, Zhang Yanjun, Li Bo, Gong Jing, Fu Yu, Xu Zhe.
Gene therapy for recessive dystrophic epidermolysis bullosa
[J]. Chinese Journal of Dermatology, 2022, 55(8): 739-743.
|
[8] |
Yang Zhou, Xu Zhe, Wang Shan, Xu Jiaosheng, Han Xiaofeng, Ma Lin.
Mutation analysis of the COL7A1 gene in 4 cases of recessive dystrophic epidermolysis bullosa
[J]. Chinese Journal of Dermatology, 2022, 55(8): 653-658.
|
[9] |
Chen Fuying, Yang Weiqin, Zhang Beibei, Wang Yumeng, Wang Jianbo, Yao Zhirong, Li Ming, .
Rare subtypes of epidermolysis bullosa: three case reports and their pedigree analysis
[J]. Chinese Journal of Dermatology, 2022, 55(8): 682-685.
|
[10] |
Li Baizhang, Kang Pan, Zhang Xiaoying, Zhu Guannan, Li Shuli, Li Chunying.
Construction and validation of a risk prediction model for diabetes mellitus in patients with vitiligo
[J]. Chinese Journal of Dermatology, 2022, 55(7): 576-582.
|
[11] |
Zhao Ying, Wang Juanjuan, Ji Jiang, Su Wenxing, Wei Yuqian, Leng Hong, Ding Yujie, Shi Xin.
Interleukin-17A-mediated psoriasis and cardiovascular comorbidities
[J]. Chinese Journal of Dermatology, 2022, 55(1): 76-79.
|
[12] |
Wang Xiaopo, Chen Zhiming, Yang Yong, Sun Jianfang .
A family of severe epidermolysis bullosa simplex caused by a de novo mutation in the KRT5 gene
[J]. Chinese Journal of Dermatology, 2021, 54(3): 229-231.
|
[13] |
Jin Xinxing, Li Sizhe, Zuo Yagang.
Role of thymic stromal lymphopoietin in various skin diseases
[J]. Chinese Journal of Dermatology, 2021, 54(10): 915-919.
|
[14] |
Zhu Guannan, Xu Feng, Yu Chen, Liu Qian, Wang Gang.
Chinese dermatologists′ perceptions of effects of diet on psoriasis: a questionnaire-based cross-sectional survey
[J]. Chinese Journal of Dermatology, 2021, 54(10): 891-897.
|
[15] |
Yu Yueqian, Bao Fangfang, Liu Hong, Zhang Furen.
A case of epidermolysis bullosa caused by mutations in the COL7A1 and PLEC genes firstly reported in China
[J]. Chinese Journal of Dermatology, 2020, 53(4): 275-278.
|